1. Comment on "KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study". (April 2017) Authors: Hughes, Amy; Clarson, Jade; Gargett, Tessa; Yu, Wenbo; Brown, Michael P.; Lopez, Angel F.; Hughes, Timothy P.; Yong, Agnes S.M. Journal: Leukemia research Issue: Volume 55(2017:Apr.) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia. (27th March 2019) Authors: Ross, David M.; Pagani, Ilaria S.; Irani, Yazad D.; Clarson, Jade; Leclercq, Tamara; Dang, Phuong; McLean, Jennifer; Saunders, Verity A.; Carne, Lisa; Reynolds, John; Ritchie, David S.; White, Deborah L.; Branford, Susan; Hughes, Timothy P.; Yong, Agnes S. M. Journal: British journal of haematology Issue: Volume 186:Number 3(2019) Page Start: e56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Successful treatment‐free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells. (30th April 2020) Authors: Irani, Yazad D.; Hughes, Amy; Clarson, Jade; Kok, Chung H.; Shanmuganathan, Naranie; White, Deborah L.; Yeung, David T.; Ross, David M.; Hughes, Timothy P.; Yong, Agnes S.M. Journal: British journal of haematology Issue: Volume 191:Number 3(2020) Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗